European digital health firm Epillo is to launch a pilot digital therapeutics (DTx) project in a strategic partnership with US-based blockchain firm Hydrus7 Labs.
Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.